|
Market Closed -
Nasdaq
23:00:00 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 221.56 USD | +4.24% |
|
+6.08% | +25.89% |
| 08-13 | Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | +4.24% | +6.08% | +25.89% | +59.56% | -34.57% | 32.74B |  | | |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
